- Q3 revenue fell 1% YoY to $202.7M (+6% sequential)
- GAAP net loss widened to -$43.9M (-$0.46/sh) vs -$27.4M (-$0.29/sh) YoY
- Raised midpoint of FY revenue guidance and agreed to divest Prenatal Health business
Bearish AI Sentiment (-3.5 / 10)
Signal #134566 · SEC 8-K
$MYGN SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $MYGN filing catalyst
Why did $MYGN trigger an AI stock catalyst alert?
$MYGN triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: -3.5/10). Headline: Myriad Genetics Q3 Loss Widens to $43.9M on $202.7M Revenue; Sells Prenatal Unit. Key points: - Q3 revenue fell 1% YoY to $202.7M (+6% sequential) - GAAP net loss widened to -$43.9M (-$0.46/sh) vs -$27.4M (-$0.29/sh) YoY - Raised midpoint of FY revenue guidance and agreed to divest Prenatal Health business
How did $MYGN stock react after the SEC filing?
After the SEC 8-K for $MYGN, observed market reaction: T0 price $6.02. Past moves do not guarantee future results.
Where can I get real-time $MYGN SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $MYGN via Telegram and the VIP Web Terminal from €10/month.